drugset / Trial / NCT03269955

The Effect of Application of TachoSil® in Pancreatoduodenectomy

NCT03269955

Phase 4 Unknown 126 enrolled Asan Medical Center
RandomizedParallel-groupSingle-blindPrevention

Summary

Fibrinogen/thrombin-coated collagen patch (TachoSil®) is known to have the effect of strengthening tissue anastomosis and promoting suturing to prevent leakage. The purpose of this study is to compare the incidence of pancreatic fistula that is most crucial for surgical outcome and complications in pancreaticoduodenectomy with those of the control group and the TachoSil® apply group. Patients who were planned to undergo pancreaticoduodenectomy without a history of chronic pancreatitis are enrolled in this open-label, single-center, randomized, single-blind, phase 4 clinical trial.

Timeline

Start
2017-02-27
Primary completion
2018-05
Completion
2018-05

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject TachoSil Other / unclassified